Novel Transcription Factor Variants through RNA-Sequencing: The Importance of Being “Alternative”
<p>Computational and experimental workflow. Schematic overview of the <span class="html-italic">in silico</span> procedures used to infer the presence of new transcription factors (TFs) transcripts from the re-analysis of our RNA-Seq datasets. The experimental approach used to validate the presence of the new variants is also depicted.</p> "> Figure 2
<p>Schematic representation of newly identified TF transcripts. Newly identified transcripts encoding TFs (black)—<span class="html-italic">ZNF266</span>, <span class="html-italic">SATB1</span>, <span class="html-italic">ELF2</span>, <span class="html-italic">SP140L</span>, <span class="html-italic">ARID5B</span>, <span class="html-italic">NCOA2</span> and <span class="html-italic">IRF1</span>—are schematically compared to known gene annotations: RefSeq (blue), AceView predictions (purple) and Gencode (red).</p> "> Figure 3
<p>Graphical representation of newly identified splicing events in TF genes. General scheme of the new alternative splicing events identified for <span class="html-italic">SATB1</span> (<b>A</b>); <span class="html-italic">ELF2</span> (<b>B</b>); <span class="html-italic">SP140L</span> (<b>C</b>); <span class="html-italic">ARID5B</span> (<b>D</b>); <span class="html-italic">NCOA2</span> (<b>E</b>) and <span class="html-italic">ZNF266</span> (<b>F</b>). For all the genes, the genomic region encompassing the gene is shown in the upper part. Nucleotide sequences (and electropherograms by Sanger sequencing) of the new splice junctions are shown below the exon/intron structure for each gene. White numbers indicate exons’ numbers. Donor and acceptor splice sites are shown in bold. Red arrows indicate the primers annealing sites.</p> "> Figure 4
<p>Multiple alignment of the <span class="html-italic">N</span>-terminal residues of the novel predicted ZNF266 variants. The evolutionary conservation of the new 67 amino acids is shown in (<b>A</b>); Krüppel-associated box (KRAB)-A and -B boxes (dashed lines) alignment with other human genes is shown in (<b>B</b>). Identical residues are indicated by “<b>*</b>”, conservation between groups of strongly and weakly similar properties by “:” and “.” respectively. Black arrow indicates the start of the canonical ZNF266 protein isoform.</p> "> Figure 5
<p><span class="html-italic">In silico</span> characterization of ZNF266 predicted protein. Panel <b>A</b> shows relative surface accessibility (RSA) per residue; 3D structure of both annotated (<b>left</b>) and new (<b>right</b>) ZNF266 isoforms are shown in panel <b>B</b>. The protein backbone is shown in grey. The arrows show the direction of the beta-sheets, which is from the <span class="html-italic">N</span>- to the <span class="html-italic">C</span>-terminus. In both panels, functional domains and motifs are highlighted. In particular, the KRAB domain of the new ZNF266 isoform is shown in green, three predicted additional ZNF motifs in orange and the annotated ZNF motifs in yellow.</p> ">
Abstract
:1. Introduction
2. Results
2.1. In Silico Identification of New Splice Isoforms of Genes Encoding Transcription Factors (TFs)
Gene Symbol | Chromosome Position | Accession Number | Primer Sequence (5'–3') | |
---|---|---|---|---|
Forward Primer | Reverse Primer | |||
ZNF266 | 19p13.2 | LN607832 | GAAGTAGAAAGGGTGGTGGC | TTCTTGTAGTTCTCCAGCATC |
SATB1 | 3p24.3 | LN626687 | CGTATGGGGAAAGAGGACAA | GCGTTTTCATAATGTTCCACC |
ELF2 | 4q31.1 | LN626691 | GAGACCGAGAATGTGGAAAC | TACTGCTGTGAACTGATGCT |
ELF2 | 4q31.1 | LN626692 | GAGACCGAGAATGTGGAAAC | TACTGCTGTGAACTGATGCT |
SP140L | 2q37.1 | KF419365/6/7 * | GGTGGGACGATGGCAGGT | CAAGTCCCTCATCTACATCC |
ARID5B | 10q21.2 | LN607831 | AGGAATGGACAGAAGGAAGC | ATGGTTTCTTTTTGCGTGGTC |
NCOA2 | 8q13.3 | LN607830 | GTGAGCCCCAAGAAGAAAGA | GACTCTCACAGCCGAACTC |
IRF1 | 5q31.1 | LN607829 | CTCCACTCTGCCTGATGAC | GATGGAGGGCAACCGGACT |
IRF1 | 5q31.1 | LN626686 | CTCCACTCTGCCTGATGAC | GATGGAGGGCAACCGGACT |
2.2. Validation of Novel TFs Transcripts
2.3. Protein Prediction of the Novel TFs Isoforms
2.4. Identification and Characterization of a Novel ZNF266 Variant
3. Discussion
4. Experimental Section
4.1. Computational Analysis of RNA-Seq Datasets
4.2. Cell Cultures
4.3. RNA Extraction and RT-PCR Assays
4.4. DNA Gel Extraction, Cloning and Sequencing
4.5. In Silico Analysis
Supplementary Materials
Acknowledgments
Author Contributions
Conflicts of Interest
References
- FANTOM Consortium and the RIKEN PMI and CLST (DGT); Forrest, A.R.; Kawaji, H.; Rehli, M.; Baillie, J.K.; de Hoon, M.J.; Lassmann, T.; Itoh, M.; Summers, K.M.; Suzuki, H.; et al. A promoter-level mammalian expression atlas. Nature 2014, 507, 462–470. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489, 57–74. [Google Scholar]
- International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004, 431, 931–945. [Google Scholar]
- Pan, Q.; Shai, O.; Lee, L.J.; Frey, B.J.; Blencowe, B.J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 2008, 40, 1413–1415. [Google Scholar] [CrossRef] [PubMed]
- Roy, B.; Haupt, L.M.; Griffiths, L.R. Alternative splicing (AS) of genes as an approach for generating protein complexity. Curr. Genomics 2013, 14, 182–194. [Google Scholar] [CrossRef] [PubMed]
- Kim, E.; Magen, A.; Ast, G. Different levels of alternative splicing among eukaryotes. Nucleic Acids Res. 2007, 35, 125–131. [Google Scholar] [CrossRef] [PubMed]
- Gamazon, E.R.; Stranger, B.E. Genomics of alternative splicing: Evolution, development and pathophysiology. Hum. Genet. 2014, 133, 679–687. [Google Scholar] [CrossRef] [PubMed]
- Wang, E.T.; Sandberg, R.; Luo, S.; Khrebtukova, I.; Zhang, L.; Mayr, C.; Kingsmore, S.F.; Schroth, G.P.; Burge, C.B. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456, 470–476. [Google Scholar] [CrossRef] [PubMed]
- Keren, H.; Lev-Maor, G.; Ast, G. Alternative splicing and evolution diversification, exon definition and function. Nat. Rev. Genet. 2010, 11, 345–355. [Google Scholar] [CrossRef] [PubMed]
- Talavera, D.; Orozco, M.; de la Cruz, X. Alternative splicing of transcription factors’ genes: Beyond the increase of proteome diversity. Comp. Funct. Genomics 2009, 2009, 905894. [Google Scholar] [CrossRef]
- Kalsotra, A.; Cooper, T.A. Functional consequences of developmentally regulated alternative splicing. Nat. Rev. Genet. 2011, 12, 715–729. [Google Scholar] [CrossRef] [PubMed]
- Aprile, M.; Ambrosio, M.R.; D’Esposito, V.; Beguinot, F.; Formisano, P.; Costa, V.; Ciccodicola, A. PPARG in human adipogenesis differential contribution of canonical transcripts and dominant negative isoforms. PPAR Res. 2014, 2014, 537865. [Google Scholar] [CrossRef] [PubMed]
- Sabatino, L.; Casamassimi, A.; Peluso, G.; Barone, M.V.; Capaccio, D.; Migliore, C.; Bonelli, P.; Pedicini, A.; Febbraro, A.; Ciccodicola, A.; et al. A novel peroxisome proliferator-activated receptor gamma isoform with dominant negative activity generated by alternative splicing. J. Biol. Chem. 2005, 280, 26517–26525. [Google Scholar] [CrossRef] [PubMed]
- Urrutia, R. KRAB-containing zinc-finger repressor proteins. Genome Biol. 2003, 4, 231. [Google Scholar] [CrossRef] [PubMed]
- Costa, V.; Aprile, M.; Esposito, R.; Ciccodicola, A. RNA-Seq and human complex diseases: Recent accomplishments and future perspectives. Eur. J. Hum. Genet. 2013, 21, 134–142. [Google Scholar] [CrossRef] [PubMed]
- Costa, V.; Angelini, C.; D’Apice, L.; Mutarelli, M.; Casamassimi, A.; Sommese, L.; Gallo, M.A.; Aprile, M.; Esposito, R.; Leone, L.; et al. Massive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21. PLoS One 2011, 6, e18493. [Google Scholar] [CrossRef] [PubMed]
- Scarpato, M.; Esposito, R.; Evangelista, D.; Aprile, M.; Ambrosio, M.R.; Angelini, C.; Ciccodicola, A.; Costa, V. AnaLysis of Expression on human chromosome 21, ALE-HSA21: A pilot integrated web resource. Database 2014, 2014, bau009. [Google Scholar] [CrossRef] [PubMed]
- Wingender, E.; Schoeps, T.; Dönitz, J. TFClass: An expandable hierarchical classification of human transcription factors. Nucleic Acids Res. 2013, 41, 165–170. [Google Scholar] [CrossRef]
- Thierry-Mieg, D.; Thierry-Mieg, J. AceView: A comprehensive cDNA-supported gene and transcripts annotation. Genome Biol. 2006, 7, S12.1–S14. [Google Scholar] [CrossRef] [PubMed]
- Boguski, M.S.; Lowe, T.M.; Tolstoshev, C.M. dbEST—Database for “expressed sequence tags”. Nat. Genet. 1993, 4, 332–333. [Google Scholar] [CrossRef] [PubMed]
- Pérez-Ortín, J.E.; Alepuz, P.; Chávez, S.; Choder, M. Eukaryotic mRNA decay: Methodologies, pathways, and links to other stages of gene expression. J. Mol. Biol. 2013, 425, 3750–3775. [Google Scholar] [CrossRef] [PubMed]
- Lee, E.J.; Jo, M.; Park, J.; Zhang, W.; Lee, J.H. Alternative splicing variants of IRF-1 lacking exons 7, 8, and 9 in cervical cancer. Biochem. Biophys. Res. Commun. 2006, 347, 882–888. [Google Scholar] [CrossRef] [PubMed]
- Costa, V.; Sommese, L.; Casamassimi, A.; Colicchio, R.; Angelini, C.; Marchesano, V.; Milone, L.; Farzati, B.; Giovane, A.; Fiorito, C.; et al. Impairment of circulating endothelial progenitors in Down syndrome. BMC Med. Genomics 2010, 3, 40. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kozak, M. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res. 1984, 12, 857–872. [Google Scholar] [CrossRef] [PubMed]
- Peng, H.; Du, Z.W.; Zhang, J.W. Identification and characterization of a novel zinc finger protein (HZF1) gene and its function in erythroid and megakaryocytic differentiation of K562 cells. Leukemia 2006, 20, 1109–1116. [Google Scholar] [CrossRef] [PubMed]
- Huang, H.D.; Horng, J.T.; Lee, C.C.; Liu, B.J. ProSplicer: A database of putative alternative splicing information derived from protein, mRNA and expressed sequence tag sequence data. Genome Biol. 2003, 4, R29. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Takeda, J.; Suzuki, Y.; Sakate, R.; Sato, Y.; Gojobori, T.; Imanishi, T.; Sugano, S. H-DBAS: human-transcriptome database for alternative splicing: Update 2010. Nucleic Acids Res. 2010, 38, D86–D90. [Google Scholar] [CrossRef] [PubMed]
- Kosti, I.; Radivojac, P.; Mandel-Gutfreund, Y. An integrated regulatory network reveals pervasive cross-regulation among transcription and splicing factors. PLoS Comput. Biol. 2012, 8, e1002603. [Google Scholar] [CrossRef] [PubMed]
- Rienzo, M.; Costa, V.; Scarpato, M.; Schiano, C.; Casamassimi, A.; Grimaldi, V.; Ciccodicola, A.; Napoli, C. RNA-Seq for the identification of novel Mediator transcripts in endothelial progenitor cells. Gene 2014, 547, 98–105. [Google Scholar] [CrossRef] [PubMed]
- Chepelev, I.; Chen, X. Alternative splicing switching in stem cell lineages. Front. Biol. 2013, 8, 50–59. [Google Scholar] [CrossRef]
- Das, S.; Jena, S.; Levasseur, D.N. Alternative splicing produces Nanog protein variants with different capacities for self-renewal and pluripotency in embryonic stem cells. J. Biol. Chem. 2011, 286, 42690–42703. [Google Scholar] [CrossRef] [PubMed]
- Gabut, M.; Samavarchi-Tehrani, P.; Wang, X.; Slobodeniuc, V.; O’Hanlon, D.; Sung, H.K.; Alvarez, M.; Talukder, S.; Pan, Q.; Mazzoni, E.O.; et al. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 2011, 147, 132–146. [Google Scholar] [CrossRef] [PubMed]
- Atlasi, Y.; Mowla, S.J.; Ziaee, S.A.; Gokhale, P.J.; Andrews, P.W. OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells 2008, 26, 3068–3074. [Google Scholar] [CrossRef] [PubMed]
- Mir, R.; Pradhan, S.J.; Galande, S. Chromatin organizer SATB1 as a novel molecular target for cancer therapy. Curr. Drug Targets 2012, 13, 1603–1615. [Google Scholar] [CrossRef] [PubMed]
- Oettgen, P.; Akbarali, Y.; Boltax, J.; Best, J.; Kunsch, C.; Libermann, T.A. Characterization of NERF, a novel transcription factor related to the Ets factor ELF1. Mol. Cell Biol. 1996, 16, 5091–5106. [Google Scholar] [PubMed]
- Dube, A.; Akbarali, Y.; Sato, T.N.; Libermann, T.A.; Oettgen, P. Role of the Ets transcription factors in the regulation of the vascular-specific Tie2 gene. Circ. Res. 1999, 84, 1177–1185. [Google Scholar] [CrossRef] [PubMed]
- Cho, J.Y.; Akbarali, Y.; Zerbini, L.F.; Gu, X.; Boltax, J.; Wang, Y.; Oettgen, P.; Zhang, D.E.; Libermann, T.A. Isoforms of the Ets transcription factor NERF/ELF2 physically interact with AML1 and mediate opposing effects on AML1-mediated transcription of the B cell-specific blk gene. J. Biol. Chem. 2004, 279, 19512–19522. [Google Scholar] [CrossRef] [PubMed]
- Yoshida, H.; Miyachi, M.; Sakamoto, K.; Ouchi, K.; Yagyu, S.; Kikuchi, K.; Kuwahara, Y.; Tsuchiya, K.; Imamura, T.; Iehara, T.; et al. PAX3-NCOA2 fusion gene has a dual role in promoting the proliferation and inhibiting the myogenic differentiation of rhabdomyosarcoma cells. Oncogene 2013, 33, 5601–5608. [Google Scholar] [CrossRef] [PubMed]
- Panagopoulos, I.; Gorunova, L.; Bjerkehagen, B.; Boye, K.; Heim, S. Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma. Oncol. Rep. 2014, 32, 40–44. [Google Scholar] [PubMed]
- Carapeti, M.; Aguiar, R.C.; Goldman, J.M.; Cross, N.C. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood 1998, 91, 3127–3133. [Google Scholar] [PubMed]
- Grondin, B.; Bazinet, M.; Aubry, M. The KRAB zinc finger gene ZNF74 encodes an RNA-binding protein tightly associated with the nuclear matrix. J. Biol. Chem. 1996, 271, 15458–15467. [Google Scholar] [CrossRef] [PubMed]
- Costa, V.; Angelini, C.; de Feis, I.; Ciccodicola, A. Uncovering the complexity of transcriptomes with RNA-Seq. J. Biomed. Biotechnol. 2010, 2010, 853916. [Google Scholar] [CrossRef]
- Kameyama, T.; Suzuki, H.; Mayeda, A. Re-splicing of mature mRNA in cancer cells promotes activation of distant weak alternative splice sites. Nucleic Acids Res. 2012, 40, 7896–7906. [Google Scholar] [CrossRef] [PubMed]
- Sorek, R.; Shamir, R.; Ast, G. How prevalent is functional alternative splicing in the human genome? Trends Genet. 2004, 20, 68–71. [Google Scholar] [CrossRef] [PubMed]
- Barash, Y.; Calarco, J.A.; Gao, W.; Pan, Q.; Wang, X.; Shai, O.; Blencowe, B.J.; Frey, B.J. Deciphering the splicing code. Nature 2010, 465, 53–59. [Google Scholar] [CrossRef] [PubMed]
- Soreq, L.; Guffanti, A.; Salomonis, N.; Simchovitz, A.; Israel, Z.; Bergman, H.; Soreq, H. Long non-coding RNA and alternative splicing modulations in Parkinson’s leukocytes identified by RNA sequencing. PLoS Comput. Biol. 2014, 10, e1003517. [Google Scholar] [CrossRef] [PubMed]
- Kent, W.J.; Sugnet, C.W.; Furey, T.S.; Roskin, K.M.; Pringle, T.H.; Zahler, A.M.; Haussler, D. The human genome browser at UCSC. Genome Res. 2002, 12, 996–1006. [Google Scholar] [CrossRef] [PubMed]
- Costa, V.; Conte, I.; Ziviello, C.; Casamassimi, A.; Alfano, G.; Banfi, S.; Ciccodicola, A. Identification and expression analysis of novel Jakmip1 transcripts. Gene 2007, 402, 1–8. [Google Scholar] [CrossRef] [PubMed]
- A Plasmid Editor (ApE). Available online: http://biologylabs.utah.edu/jorgensen/wayned/ape/ (accessed on 3 October 2013).
- Kent, W.J. BLAT—The BLAST-like alignment tool. Genome Res. 2002, 12, 656–664. [Google Scholar] [CrossRef] [PubMed]
- The UniProt Database. Available online: http://www.uniprot.org (accessed on 29 September 2014).
- Larkin, M.A.; Blackshields, G.; Brown, N.P.; Chenna, R.; McGettigan, P.A.; McWilliam, H.; Valentin, F.; Wallace, I.M.; Wilm, A.; Lopez, R.; et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23, 2947–2948. [Google Scholar] [CrossRef] [PubMed]
- Petersen, B.; Petersen, T.N.; Andersen, P.; Nielsen, M.; Lundegaard, C. A generic method for assignment of reliability scores applied to solvent accessibility predictions. BMC Struct. Biol. 2009, 9, 51. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Y. I-TASSER server for protein 3D structure prediction. BMC Bioinform. 2008, 9, 40. [Google Scholar] [CrossRef]
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Scarpato, M.; Federico, A.; Ciccodicola, A.; Costa, V. Novel Transcription Factor Variants through RNA-Sequencing: The Importance of Being “Alternative”. Int. J. Mol. Sci. 2015, 16, 1755-1771. https://doi.org/10.3390/ijms16011755
Scarpato M, Federico A, Ciccodicola A, Costa V. Novel Transcription Factor Variants through RNA-Sequencing: The Importance of Being “Alternative”. International Journal of Molecular Sciences. 2015; 16(1):1755-1771. https://doi.org/10.3390/ijms16011755
Chicago/Turabian StyleScarpato, Margherita, Antonio Federico, Alfredo Ciccodicola, and Valerio Costa. 2015. "Novel Transcription Factor Variants through RNA-Sequencing: The Importance of Being “Alternative”" International Journal of Molecular Sciences 16, no. 1: 1755-1771. https://doi.org/10.3390/ijms16011755